Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Low-Risk Patients
Authors:
- Stefano RosatoSRStefano Rosato
- Francesco SantiniFSFrancesco Santini
- Marco BarbantiMBMarco Barbanti
- Fausto BiancariFausto Biancari
- Paola D’eRrigoPDPaola D’eRrigo
- Francesco OnoratiFrancesco Onorati
- Corrado TamburinoCTCorrado Tamburino
- Marco RanucciMarco Ranucci
- Remo Daniel CovelloRCRemo Daniel Covello
- Gennaro SantoroGSGennaro Santoro
- Claudio GrossiCGClaudio Grossi
- Martina VenturaMVMartina Ventura
- 1 May 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 9 (5) , e003326
Abstract
Background—: The proven efficacy of transcatheter aortic valve implantation (TAVI) in high-risk patients is leading to the expansion of its indications toward lower-risk patients. However, this shift is not supported by meaningful evidence of its benefit over surgical aortic valve replacement (SAVR). This analysis aims to describe outcomes of TAVI versus SAVR in low-risk patients. Methods and Results—: We compared the outcome after TAVI and SAVR of low-risk patients (European System for Cardiac Operative Risk Evaluation II [EuroSCORE II] P =0.82). Cardiac tamponade, permanent pacemaker implantation, major vascular damage, and moderate-to-severe paravalvular regurgitation were significantly more frequent after TAVI compared with SAVR. Stroke rates were equal in the study groups. SAVR was associated with higher risk of cardiogenic shock, severe bleeding, and acute kidney injury. At 3 years, survival was 83.4% after SAVR and 72.0% after TAVI ( P =0.0015), whereas freedom from major adverse cardiac and cerebrovascular events was 80.9% after SAVR and 67.3% after TAVI ( P <0.001). Conclusions—: In patients with low operative risk, significantly better 3-year survival and freedom from major adverse cardiac and cerebrovascular events were observed after SAVR compared with TAVI. Further studies on new-generation valve prostheses are necessary before expanding indications of TAVI toward lower-risk patients.Keywords
This publication has 23 references indexed in Scilit:
- 1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve ReplacementJACC, 2015
- 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trialThe Lancet, 2015
- Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve ReplacementsJACC, 2015
- Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve StenosisJACC, 2015
- Immediate outcome after sutureless versus transcatheter aortic valve replacementHeart and Vessels, 2015
- Patient selection for TAVI in 2014: is it justified to treat low- or intermediate-risk patients? The cardiologist’s viewEuroIntervention, 2014
- Patient selection for TAVI in 2014: is there a justification for treating low- or intermediate-risk patients? The surgeon’s viewEuroIntervention, 2014
- A 3-Center Comparison of 1-Year Mortality Outcomes Between Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement on the Basis of Propensity Score Matching Among Intermediate-Risk Surgical PatientsJACC: Cardiovascular Interventions, 2013
- Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score–matched case-control studyAmerican Heart Journal, 2012
- Improvements in Transcatheter Aortic Valve Implantation Outcomes in Lower Surgical Risk PatientsJACC, 2012